share_log

DEFA14A: Others

DEFA14A: Others

DEFA14A:其他
美股SEC公告 ·  2024/11/12 09:36

Moomoo AI 已提取核心信息

180 Life Sciences Corp. has announced the availability of proxy materials for its upcoming Annual Meeting of Stockholders scheduled for December 27, 2024. The meeting will be held online at 1:00 P.M. Pacific Time. Stockholders are encouraged to access and review the proxy materials available on the internet prior to voting. The agenda for the meeting includes the election of three Class II directors, the adoption of the third amendment to the company's charter, advisory resolutions on executive compensation, and approval of stock issuances for NASDAQ compliance. Additionally, the ratification of M&K CPAS, PLLC as independent auditors for the fiscal year ending December 31, 2024, will be addressed. The record date for stockholders entitled to vote has been set as October 31, 2024. The Board of Directors recommends voting 'for' all the proposals. Stockholders have until 11:59 PM Eastern Time on December 26, 2024, to submit their voting instructions online.
180 Life Sciences Corp. has announced the availability of proxy materials for its upcoming Annual Meeting of Stockholders scheduled for December 27, 2024. The meeting will be held online at 1:00 P.M. Pacific Time. Stockholders are encouraged to access and review the proxy materials available on the internet prior to voting. The agenda for the meeting includes the election of three Class II directors, the adoption of the third amendment to the company's charter, advisory resolutions on executive compensation, and approval of stock issuances for NASDAQ compliance. Additionally, the ratification of M&K CPAS, PLLC as independent auditors for the fiscal year ending December 31, 2024, will be addressed. The record date for stockholders entitled to vote has been set as October 31, 2024. The Board of Directors recommends voting 'for' all the proposals. Stockholders have until 11:59 PM Eastern Time on December 26, 2024, to submit their voting instructions online.
180 Life Sciences Corp.已宣布其即将于2024年12月27日举行的股东年度大会的代理材料已可获得。会议将在太平洋时间下午1:00在线上举行。鼓励股东在投票前访问并审阅互联网上提供的代理材料。会议议程包括选举三名II类董事、通过公司宪章的第三项修正案、执行薪酬的咨询决议和为纳斯达克合规批准的股份发行。此外,将讨论批准M&k CPAS,PLLC作为截至2024年12月31日财政年度的独立审计师。有权投票的股东记录日期已设定为2024年10月31日。董事会建议投票支持所有提案。股东需在2024年12月26日东部时间晚上11:59之前在线提交他们的投票指示。
180 Life Sciences Corp.已宣布其即将于2024年12月27日举行的股东年度大会的代理材料已可获得。会议将在太平洋时间下午1:00在线上举行。鼓励股东在投票前访问并审阅互联网上提供的代理材料。会议议程包括选举三名II类董事、通过公司宪章的第三项修正案、执行薪酬的咨询决议和为纳斯达克合规批准的股份发行。此外,将讨论批准M&k CPAS,PLLC作为截至2024年12月31日财政年度的独立审计师。有权投票的股东记录日期已设定为2024年10月31日。董事会建议投票支持所有提案。股东需在2024年12月26日东部时间晚上11:59之前在线提交他们的投票指示。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息